{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:15:56Z","timestamp":1784711756187,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pediatric liver transplantation rejection affects 20% of children. Currently, liver biopsy, expensive and invasive, is the best method of diagnosis. Discovery and validation of clinical biomarkers from blood or other biospecimens would improve clinical care. For this study, stored plasma samples were utilized from two cross-sectional cohorts of liver transplant patients at Children\u2019s Healthcare of Atlanta. High resolution metabolic profiling was completed using established methods. Children with (n\u2009=\u200918) or without (n\u2009=\u200925) acute cellular rejection were included in the analysis (n\u2009=\u200943 total). The mean age of these racially diverse cohorts ranged from 12.6\u00a0years in the rejection group and 13.6\u00a0years in the no rejection group. Linear regression provided 510 significantly differentiating metabolites between groups, and OPLS-DA showed 145 metabolites with VIP\u2009&gt;\u20092. A total of 95 overlapping significant metabolites between OPLS-DA and linear regression analyses were detected. Pathway analysis (p\u2009&lt;\u20090.05) showed bile acid biosynthesis and tryptophan metabolism as the top two differentiating pathways. Network analysis also identified tryptophan and clustered with liver enzymes and steroid use. We conclude metabolic profiling of plasma from children with acute liver transplant rejection demonstrates\u2009&gt;\u2009500 significant metabolites. This result suggests that development of a non-invasive biomarker-based test is possible for rejection screening.<\/jats:p>","DOI":"10.1038\/s41598-022-18957-4","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T10:08:46Z","timestamp":1667556526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Metabolomics profiling in acute liver transplant rejection in a pediatric population"],"prefix":"10.1038","volume":"12","author":[{"given":"Jennifer K.","family":"Frediani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara S.","family":"Beyh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianna L.","family":"Westbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Cleeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ViLinh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean P.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam B.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,4]]},"reference":[{"key":"18957_CR1","unstructured":"Organ transplant trends|More transplants than ever. UNOS https:\/\/unos.org\/data\/transplant-trends\/."},{"key":"18957_CR2","unstructured":"National Data-OPTN. https:\/\/optn.transplant.hrsa.gov\/data\/view-data-reports\/national-data\/."},{"key":"18957_CR3","unstructured":"Health Resources and Services Adminstration. Scientific Registry of Transplant Recipients. https:\/\/srtr.transplant.hrsa.gov\/annual_reports\/2019\/Liver.aspx."},{"key":"18957_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13605","author":"SA Elisofon","year":"2019","unstructured":"Elisofon, S. A. et al. Society of pediatric liver transplantation: Current registry status 2011\u20132018. Pediatr. Transplant. https:\/\/doi.org\/10.1111\/petr.13605 (2019).","journal-title":"Pediatr. Transplant."},{"key":"18957_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.12659\/AOT.913800","volume":"24","author":"NJ Skill","year":"2019","unstructured":"Skill, N. J. et al. Metabolomic characterization of human model of liver rejection identifies aberrancies linked to cyclooxygenase (COX) and nitric oxide synthase (NOS). Ann. Transplant. 24, 341\u2013349 (2019).","journal-title":"Ann. Transplant."},{"key":"18957_CR6","doi-asserted-by":"publisher","first-page":"e1128","DOI":"10.1542\/peds.2008-1363","volume":"122","author":"VL Ng","year":"2008","unstructured":"Ng, V. L. et al. Outcomes of 5-year survivors of pediatric liver transplantation: Report on 461 children from a north american multicenter registry. Pediatrics 122, e1128\u2013e1135 (2008).","journal-title":"Pediatrics"},{"key":"18957_CR7","first-page":"971","volume":"23","author":"DAH Neil","year":"2010","unstructured":"Neil, D. A. H. & H\u00fcbscher, S. G. Current views on rejection pathology in liver transplantation. Transpl. Int. Off. J. Eur. Soc. Organ Transplant. 23, 971\u2013983 (2010).","journal-title":"Transpl. Int. Off. J. Eur. Soc. Organ Transplant."},{"key":"18957_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S1499-3872(15)60391-5","volume":"14","author":"KP Au","year":"2015","unstructured":"Au, K. P. et al. Clinical factors affecting rejection rates in liver transplantation. Hepatobiliary Pancreat. Dis. Int. HBPD INT 14, 367\u2013373 (2015).","journal-title":"Hepatobiliary Pancreat. Dis. Int. HBPD INT"},{"key":"18957_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/lt.500050418","volume":"5","author":"DG Ormonde","year":"1999","unstructured":"Ormonde, D. G. et al. Banff schema for grading liver allograft rejection: Utility in clinical practice. Liver Transpl. Surg. 5, 261\u2013268 (1999).","journal-title":"Liver Transpl. Surg."},{"key":"18957_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/lt.20661","volume":"12","author":"SS Sundaram","year":"2006","unstructured":"Sundaram, S. S., Melin-Aldana, H., Neighbors, K. & Alonso, E. M. Histologic characteristics of late cellular rejection, significance of centrilobular injury, and long-term outcome in pediatric liver transplant recipients. Liver Transpl. 12, 58\u201364 (2006).","journal-title":"Liver Transpl."},{"key":"18957_CR11","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jhep.2014.04.023","volume":"61","author":"M Cortes","year":"2014","unstructured":"Cortes, M. et al. Metabolomics discloses donor liver biomarkers associated with early allograft dysfunction. J. Hepatol. 61, 564\u2013574 (2014).","journal-title":"J. Hepatol."},{"key":"18957_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.1349-7006.2009.01086.x","volume":"100","author":"H Gao","year":"2009","unstructured":"Gao, H. et al. Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis. Cancer Sci. 100, 782\u2013785 (2009).","journal-title":"Cancer Sci."},{"key":"18957_CR13","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/jssc.201100408","volume":"34","author":"X Lin","year":"2011","unstructured":"Lin, X. et al. Classification and differential metabolite discovery of liver diseases based on plasma metabolic profiling and support vector machines. J. Sep. Sci. 34, 3029\u20133036 (2011).","journal-title":"J. Sep. Sci."},{"key":"18957_CR14","doi-asserted-by":"publisher","first-page":"6590","DOI":"10.1158\/0008-5472.CAN-11-0885","volume":"71","author":"AD Patterson","year":"2011","unstructured":"Patterson, A. D. et al. Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling. Cancer Res. 71, 6590\u20136600 (2011).","journal-title":"Cancer Res."},{"key":"18957_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/hepr.12012","volume":"43","author":"XPD Verhelst","year":"2013","unstructured":"Verhelst, X. P. D., Troisi, R. I., Colle, I., Geerts, A. & van Vlierberghe, H. Biomarkers for the diagnosis of acute cellular rejection in liver transplant recipients: A review. Hepatol. Res. Off. J. Jpn. Soc. Hepatol. 43, 165\u2013178 (2013).","journal-title":"Hepatol. Res. Off. J. Jpn. Soc. Hepatol."},{"key":"18957_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-4939-7592-1_2","volume":"1730","author":"B Everts","year":"2018","unstructured":"Everts, B. Metabolomics in immunology research. Methods Mol. Biol. Clifton NJ 1730, 29\u201342 (2018).","journal-title":"Methods Mol. Biol. Clifton NJ"},{"key":"18957_CR17","first-page":"943","volume":"22","author":"AK Baumann","year":"2016","unstructured":"Baumann, A. K. et al. Preferential accumulation of T helper cells but not cytotoxic T cells characterizes benign subclinical rejection of human liver allografts. Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc. 22, 943\u2013955 (2016).","journal-title":"Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"key":"18957_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.immuni.2010.09.002","volume":"33","author":"JD Powell","year":"2010","unstructured":"Powell, J. D. & Delgoffe, G. M. The mammalian target of rapamycin: Linking T cell differentiation, function, and metabolism. Immunity 33, 301\u2013311 (2010).","journal-title":"Immunity"},{"key":"18957_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5114\/ceh.2019.85076","volume":"5","author":"K Shams","year":"2019","unstructured":"Shams, K. et al. Fas, FasL and Foxp3 gene expression in post-liver transplant autoimmune hepatitis patients with and without acute rejection. Clin. Exp. Hepatol. 5, 103\u2013108 (2019).","journal-title":"Clin. Exp. Hepatol."},{"key":"18957_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2174\/138920007780362536","volume":"8","author":"G Brandacher","year":"2007","unstructured":"Brandacher, G., Margreiter, R. & Fuchs, D. Implications of IFN-gamma-mediated tryptophan catabolism on solid organ transplantation. Curr. Drug Metab. 8, 273\u2013282 (2007).","journal-title":"Curr. Drug Metab."},{"key":"18957_CR21","first-page":"95","volume":"18","author":"TM Bauer","year":"2005","unstructured":"Bauer, T. M. et al. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: Tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo. Transpl. Int. Off. J. Eur. Soc. Organ Transplant. 18, 95\u2013100 (2005).","journal-title":"Transpl. Int. Off. J. Eur. Soc. Organ Transplant."},{"key":"18957_CR22","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1089\/omi.2014.0094","volume":"18","author":"MTPR Perera","year":"2014","unstructured":"Perera, M. T. P. R. et al. Biomarker differences between cadaveric grafts used in human orthotopic liver transplantation as identified by coulometric electrochemical array detection (CEAD) metabolomics. Omics J. Integr. Biol. 18, 767\u2013777 (2014).","journal-title":"Omics J. Integr. Biol."},{"key":"18957_CR23","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1194\/jlr.R900007-JLR200","volume":"50","author":"PB Hylemon","year":"2009","unstructured":"Hylemon, P. B. et al. Bile acids as regulatory molecules. J. Lipid Res. 50, 1509\u20131520 (2009).","journal-title":"J. Lipid Res."},{"key":"18957_CR24","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/elps.201000512","volume":"32","author":"C Legido-Quigley","year":"2011","unstructured":"Legido-Quigley, C. et al. Bile UPLC-MS fingerprinting and bile acid fluxes during human liver transplantation. Electrophoresis 32, 2063\u20132070 (2011).","journal-title":"Electrophoresis"},{"key":"18957_CR25","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/toxsci\/kfv198","volume":"148","author":"YM Go","year":"2015","unstructured":"Go, Y. M. et al. Reference standardization for mass spectrometry and high-resolution metabolomics applications to exposome research. Toxicol. Sci. 148, 531\u2013543 (2015).","journal-title":"Toxicol. Sci."},{"key":"18957_CR26","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1039\/c0an00333f","volume":"135","author":"JM Johnson","year":"2010","unstructured":"Johnson, J. M., Yu, T., Strobel, F. H. & Jones, D. P. A practical approach to detect unique metabolic patterns for personalized medicine. Analyst 135, 2864\u20132870 (2010).","journal-title":"Analyst"},{"key":"18957_CR27","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1021\/pr301053d","volume":"12","author":"T Yu","year":"2013","unstructured":"Yu, T., Park, Y., Li, S. & Jones, D. P. Hybrid feature detection and information accumulation using high-resolution LC-MS metabolomics data. J. Proteome Res. 12, 1419\u20131427 (2013).","journal-title":"J. Proteome Res."},{"key":"18957_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-14-15","volume":"14","author":"K Uppal","year":"2013","unstructured":"Uppal, K. et al. xMSanalyzer: Automated pipline for improved feature detection and downstream analyisis of large-scale, non-targeted metabolomics data. BMC Bioinform. 14, 1\u201312 (2013).","journal-title":"BMC Bioinform."},{"key":"18957_CR29","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/bioinformatics\/btx656","volume":"34","author":"K Uppal","year":"2018","unstructured":"Uppal, K., Ma, C., Go, Y. M., Jones, D. P. & Wren, J. xMWAS: A data-driven integration and differential network analysis tool. Bioinformatics 34, 701\u2013702 (2018).","journal-title":"Bioinformatics"},{"key":"18957_CR30","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1021\/acs.analchem.6b01214","volume":"89","author":"K Uppal","year":"2017","unstructured":"Uppal, K., Walker, D. I. & Jones, D. P. xMSannotator: An R package for network-based annotation of high-resolution metabolomics data. Anal. Chem. 89, 1063\u20131067 (2017).","journal-title":"Anal. Chem."},{"key":"18957_CR31","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1021\/es5002105","volume":"48","author":"EL Schymanski","year":"2014","unstructured":"Schymanski, E. L. et al. Identifying small molecules via high resolution mass spectrometry: Communicating confidence. Environ. Sci. Technol. 48, 2097\u20132098 (2014).","journal-title":"Environ. Sci. Technol."},{"key":"18957_CR32","doi-asserted-by":"publisher","first-page":"D801","DOI":"10.1093\/nar\/gks1065","volume":"41","author":"DS Wishart","year":"2013","unstructured":"Wishart, D. S. et al. HMDB 3.0\u2014the human metabolome database in 2013. Nucleic Acids Res. 41, D801-807 (2013).","journal-title":"Nucleic Acids Res."},{"key":"18957_CR33","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353\u2013D361 (2017).","journal-title":"Nucleic Acids Res."},{"key":"18957_CR34","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/01.ftd.0000179845.53213.39","volume":"27","author":"CA Smith","year":"2005","unstructured":"Smith, C. A. et al. METLIN: A metabolite mass spectral database. Ther. Drug Monit. 27, 747\u2013751 (2005).","journal-title":"Ther. Drug Monit."},{"key":"18957_CR35","doi-asserted-by":"publisher","first-page":"e1003123","DOI":"10.1371\/journal.pcbi.1003123","volume":"9","author":"S Li","year":"2013","unstructured":"Li, S. et al. Predicting network activity from high throughput metabolomics. PLoS Comput. Biol. 9, e1003123 (2013).","journal-title":"PLoS Comput. Biol."},{"key":"18957_CR36","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1021\/acs.chemrestox.6b00179","volume":"29","author":"K Uppal","year":"2016","unstructured":"Uppal, K. et al. Computational metabolomics: A framework for the million metabolome. Chem. Res. Toxicol. 29, 1956\u20131975 (2016).","journal-title":"Chem. Res. Toxicol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18957-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18957-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18957-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T12:16:03Z","timestamp":1667564163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18957-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18957"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18957-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,4]]},"assertion":[{"value":"1 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18663"}}